2016, Number 3
<< Back Next >>
Rev Cubana Plant Med 2016; 21 (3)
Evaluation of the antiproliferative activity of methanolic extracts of plants from the Leguminosae family
Olmedo ADA, Marrone PNS, Espinosa RAF, Guerra TCP, Prashad GM
Language: Spanish
References: 24
Page: 272-283
PDF size: 147.53 Kb.
ABSTRACT
Introduction: the
Leguminosae family is rich in isoflavonoids potentially effective
against cancer. No studies have been conducted of Panamanian species from this
family to explore their possible use in the treatment of breast and prostate cancer,
two main causes of mortality among the adult population in Panama.
Objective: evaluate the antiproliferative effect of methanolic extracts from the
Leguminosae family against estrogen-dependent breast cancer (ER+) and androgendependent
prostate cancer (AR+).
Materials: all 69 species of plants from this family were collected from the provinces
of Veraguas and Darién in the Republic of Panama. Dried, pulverized material from
various parts of the plants was macerated in methanol for 24 h with stirring. The
material obtained was filtered, concentrated in a rotary evaporator at ‹ 40°C, and
lyophilized. The crude extracts obtained were evaluated for breast cancer cell lines
MCF-7(ER+) and MCF-7(ER-), and prostate cancer cell lines (CaP (AR+)), using the
antiproliferative assay with sulphorhodamine (SRB) and tetrazolium (MTT).
Results: the most active extracts against estrogen-dependent breast cancer (ER+)
were obtained from Neptunia pubescens (fruit),
Zygia latifolia (stem) and
Albizia
adinocephala (bark) with GI50 values of 1.1 to 5.9 µg/ml, whereas the most active
extracts against androgen-dependent prostate cancer (AR+) were obtained from
Zygia latifolia (leaves),
Pithecellobium dulce (leaves) and
Acosmium panamense
(stem), with GI50 values of 1.2 to 5.1 µg/ml. Additionally, extract from
Albizia
adinocephala (bark) was active against breast cancer expressing receptor HER-2, with
an CI50 of 4.8 µg/ml.
Conclusions: crude extracts from promising species could be useful as potential
sources of substances with antiproliferative activity against receptor-dependent
cancers (ER+), (AR+) and (HER-2+).
REFERENCES
Kew Royal Botanic Gardens [Internet]. 2015. [citado 17 mar 2015] Disponible en: http://kew.org/.
Singh J, Basu PS. Non-nutritive bioactive compounds in pulses and their impact on human health: an overview. Food and Nutr. Sci. 2012;3:1664-72. Disponible en: http://dx.doi.org/10.4236/fns.2012.312218.
Gulewicz P, Martinez-Villaluenga C, Kasprowicz-Potocka M, Frias J. Non-nutritive compounds in Fabaceae family seeds and the improvement of their nutritional quality by traditional processing: a review. Pol. J. Food Nutr. Sci. 2014;64(2):75-89. DOI: 10.2478/v10222-012-0098-9
Correa MD, Galdames C, Stapf M. Catálogo de las plantas vasculares de Panamá. Editorial Novoart; 2004.
GLOBOCAN. Estimated cancer incidence, mortality and prevalence worldwide in 2012. World Health Organization. [citado 20 ene 2015] Disponible en: http://globocan.iarc.fr/Default.aspx.
Valverde Z, Ruiloba AM. Indicadores básicos de salud del Ministerio de Salud. Dirección Nacional de Planificación. República de Panamá. [citado 10 feb 2015] Disponible en: http://www.minsa.gob.pa/sites/default/files/publicaciongeneral/ind._basicos_pma_2014
May, FEB. Novel drugs that target the estrogen-related receptor alpha: their therapeutic potential in breast cancer. Cancer Management and Research. 2014;6:225-52.
Bombonati A, Sgroi DC. The molecular pathology of breast cancer progression. J Pathol. 2011;223(2):307-17.
Dehm SM, Tindall DJ. 2007. Androgen receptor structural and functional elements: role and regulation in prostate cancer. Mol. Endocrinol. 2007;21:2855-63.
Gelmann EP. Molecular biology of the androgen receptor. J Clin Oncol. 2002;20:3001-35.
Zhu ML, Kyprianou N. Androgen receptor and growth factor signaling crosstalk in prostate cancer cells. Endocr Relat Cancer. 2008;15:841-49.
Hara T, Miyazaki H, Lee A, Tran CP, Reiter RE. Androgen receptor and invasion in prostate cancer. Cancer Res. 2008;68:1128-35.
Skehan P, Storeng R, Scudiero D, Monks A, McMahon J, Vistica D, et al. New colorimetric cytotoxicity assay for anticancer-drug screening. J. Natl.Cancer Inst. 1990;4:1107-12.
Monks A, Scudiero A, Johnson GS, Pauli KD, Sausville EA. The NCI anti-cancer drug screen: a smart screen to identify effectors of novel targets. Anticancer Drug Des. 1997;12:533-41.
Kim HS, Han SY, Yoo SD, Lee BM, Park KL. Potential estrogenic effects of bisphenol-A estimated by in vitro and in vivo combination assay. J Toxicol Sci. 2001;26(3):111-18.
Esparís-Ogando A, Díaz-Rodríguez E, Montero JC, Yuste L, Crespo P, Pandiella A. Erk5 participates in neuregulin signal transduction and is constitutively active in breast cancer cells overexpressing ErbB2. Mol. Cell. Biol. 2002;22:270-85.
Yuste L, Montero JC, Esparís-Ogando A, Pandiella A. Activation of ErbB2 by Overexpression or by transmembrane neuregulin results in differential signaling and sensitivity to herceptin. Cancer Res. 2005;65:6801-10.
Williams R, Patel U, Doyle BJ, Locklear TD, Perez AL, Mahady GB. Antiestrogenic and anti-HER2 activities of allspice (Pimenta dioica L., Myrtaceae) extracts in MCF-7 and SK-BR3 breast cancer cells. DOI: 10.1055/s-0034-1382723. American Society of Pharmacognosy. Annual Meeting - Held in conjunction with the 14th Annual Oxford International Conference on the Science of Botanicals. April, 2014.
Chiu J-H, Chang C-J, Wu J-C, Liu H-J, Wen C-S, Hsu C-H, et al. Screening to identify commonly used Chinese herbs that affect ERBB2 and ESR1 gene expression using the human breast cancer MCF-7 cell line. Evidence-based complementary and alternative medicine. 2014; Article ID 965486, 11 pages. http://dx.doi.org/10.1155/2014/965486.
Cherdshewasart W, Traisup V, Picha P. Determination of the estrogenic activity of wild phytoestrogen-rich Pueraria mirifica by MCF-7 proliferation assay. J Reprod Dev 2008;54(1):63-67.
Tsai C-H, Lin F-M, Yang Y-C, Lee M-T, Cha T-L, Wu G-J, et al. Herbal extract of Wedelia chinensis attenuates androgen receptor activity and orthotopic growth of prostate cancer in nude mice. Clin. Cancer Res. 2009;15(17):5435-44.
Shankar K D, S. Kirti L. Prenylated flavonoids from bark of Pithecellobium dulce. J. Nat. Products. 2014;4(1):43-6.
Wiedenfeld H, Andrade-Cetto A. Pyrone glycosides from Acosmium panamense (Benth.) Yacolev. Z. Naturforsch. 2003;58c:637-39.
Ovenden SPB, Cao S, Leong C, Flotow H, Gupta MP, Buss AD, Butler MS. Spermine alkaloids from Albizia adinocephala with activity against Plasmodium falciparum plasmepsin II. Phytochemistry 2002;60:175-77.